All News
Day 3 - Top 5 from EULAR 2020
These were my top abstracts from Thursday, 4th of June at EULAR 2020:
Read Article
Are we doing our best treating seronegative arthritides?
Every time a big scientific meeting ends I ask myself a question: how is it going to affect the way I treat my patients? This year the question pertains to management of axial spondyloarthropathies and psoriatic arthritis.
Read Article
#EULAR2020 #op0202-hpr 🇬🇧 study remind that resistant training benefits patients with inflammatory arthritides: improved function, wellbeing, self-efficacy, strength and fatigue.improved balance&endurance helps prevent falls @RheumNow https://t.co/MH7VD6zH9t
Olga Petryna DrPetryna ( View Tweet)
Do patients with early RA need to see a rheumatologist in the first 6w after Sx onset, or will 12w do?
Getting in before 6w is better for drug-free remission than 12w, but not for radiographic progression - although >12w is too long!
Leiden/ESPOIR OP0222 #EULAR2020 @RheumNow https://t.co/uaLsK4TMSR
David Liew drdavidliew ( View Tweet)
For your new diagnosis RA patients, how long have they typically had symptoms for by the time they first see you?
#EULAR2020 @RheumNow
David Liew drdavidliew ( View Tweet)
Lots of talk about best bDMARDs in RA-ILD, but what about in RA-assoc bronchiectasis?
@Yuz6Yusof found rituximab had better 'lung survival' vs TNFi (similar baseline stats)
Something to consider in these difficult-to-treat pts?
@LeedsBRC Newcastle THU0143 #EULAR2020 @RheumNow https://t.co/XpffkDNqhU
David Liew drdavidliew ( View Tweet)
People with #rheumatoid #arthritis reporting major stressors in life had worse #pain, #disability, #depression, #fatigue and sleep disturbance at diagnosis and a year later - despite control of disease. Andersen et al (2020) https://t.co/zbPbK49mvD #EULAR2020goesvirtual #EULARHPR https://t.co/qiiBa2h5ez
Dr Mwidimi Ndosi ndosie ( View Tweet)
#EULAR2020 Dr. V Ritschl:EULAR Task Force on Patient Adherance: 30-80% of pts do not adhere to Rx. resulting in ⬆️dz severity, pain, fatigue, depression, decreased in function, physical activity. HCPs should discuss adherance reg. & explore factors affecting adherance. @RheumNow
k dao KDAO2011 ( View Tweet)
ENbrel works in long term for the few people left on the drug at 10 yrs with SpA. Enormous dropout. If you are still on Rx for a decade you are in the minority. Drop out of TNFi in SpA mirrors RA & PsA @RheumNow @eular_org @CRASCRRheum @earlyarthritis #EULAR2020 https://t.co/dLS2fw5uRP
Janet Pope Janetbirdope ( View Tweet)
Your #RA patients in low disease or remission, do you maintain, reduce or stop DMARDs #EULAR2020
Dr. John Cush RheumNow ( View Tweet)
#EULAR2020 Updated RA Mgmt Recc
Main points:
1. MTX 1st line (if contraind, then SSZ/LEF; NOT HCQ)
2. Add bDMARD/JAKi if 1st csDMARD doesn't work + poor Px
3. Use IL-6i or JAKi for pts who can only take monoRx and failed csDMARD
@RheumNow
https://t.co/AIXz2dEOrX
k dao KDAO2011 ( View Tweet)
Study of the French registries for TCZ, RTX, ABA, compared the risk of GI perforations (GIP). GIP risk was higher with TCZ (vs RTX,ABA) but was largely due to TCZ increasing the risk of diverticulitis. #EULAR2020 #OP0022 https://t.co/MGGWiVh5Jv https://t.co/nC2NblYnGO
Links:
Dr. John Cush RheumNow ( View Tweet)
Do not be tempted to stop MTX or other DMARDs perioperatively! They probably help rather than harm #EULAR2020 https://t.co/jb4ZuZlqSu
Christos Koutsianas Dr_C_Koutsianas ( View Tweet)
RA pt not responding to a 1st biologic; what you predict in a Head to Head - Abatacept vs Upadacitinib?
Dr. John Cush RheumNow ( View Tweet)
#EULAR2020 #fri0505 Still’s pts who are able to achieve remissions w/longer itnervals btw tocilizumab infusions & lower dose of prednisone more likely to successfully withdraw Toci. Time to symptom recurrence in relapse group 7.8 mo. Older pts more likely to relapse @RheumNow
Olga Petryna DrPetryna ( View Tweet)
Main factors influencing #physicalactivity in inflammatory #arthritis patients are psychological
➡️Main factor related to knowledge of benefits of #exercise & symptoms
➡️Modifiable
➡️Health professional support key
FRI0642-HPR #EULAR2020
👉🏽https://t.co/Vdc7rjnC6Y
by @DavergneT https://t.co/aMUHA5IMrn
Dr Ai Lyn Tan DrAiLynTan ( View Tweet)
Don’t forget significant fibrosis with ILD has +RCT with nintedanib INBUILD study. Lots of buzz of RA ILD where MTX is OK, TNFi may have more ILD than other bDMARDs, biomatkers KL-6 @eular_org OP0038 #EULAR2020 @CRASCRRheum https://t.co/OihF3LmNYQ
Janet Pope Janetbirdope ( View Tweet)
Can we predict which RA pts will have secondary failure to TNFi in advance?
B-cell activating factor (BAFF) may play a role, and in age >54, pre-TNFi BAFF levels predict anti-drug Ab.
A potential step toward better drug survival?
La Paz, Madrid THU0170 #EULAR2020 @RheumNow https://t.co/NRQHO2cVuf
David Liew drdavidliew ( View Tweet)
Predictors of not achieving remission in early RA, in Canadian CATCH cohort vary by sex:
men: seropos, smokers
women: obesity, TJC, lower education
Different mechanisms of poor outcomes in early RA in men and women?
@earlyarthritis SAT0053 #EULAR2020 @RheumNow https://t.co/fRgm6vtlPL
David Liew drdavidliew ( View Tweet)
